Your session is about to expire
← Back to Search
Cohort 1 for HIV/AIDS
N/A
Recruiting
Research Sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at study participant completion (up until 7 years)
Awards & highlights
Summary
IMPAACT 2028 is an observational prospective study to characterize a cohort of early treated children who may participate in future research related to HIV remission or cure. Up to approximately 250 participants will be in the study for approximately seven years. No intervention is provided in the study.
Eligible Conditions
- HIV/AIDS
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ at study participant completion (up until 7 years)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at study participant completion (up until 7 years)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Clinical Outcome Measures - Cumulative incidence of WHO clinical Stage 3 or Stage 4 conditions
Clinical Outcome Measures - Cumulative incidence of medical conditions that required hospitalization, resulted in persistent or significant disability or incapacity, were life threatening, or resulted in death
Clinical Outcome Measures - Cumulative incidence of mortality
+12 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Cohort 1Experimental Treatment1 Intervention
Children living with perinatally-acquired HIV who received early treatment in IMPAACT network studies or other research studies sponsored by the United States National Institutes of Health.
Find a Location
Who is running the clinical trial?
International Maternal Pediatric Adolescent AIDS Clinical Trials GroupLead Sponsor
34 Previous Clinical Trials
11,669 Total Patients Enrolled
National Institute of Allergy and Infectious Diseases (NIAID)NIH
3,302 Previous Clinical Trials
5,501,192 Total Patients Enrolled
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH
2,014 Previous Clinical Trials
2,696,584 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger